{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:13:21Z","timestamp":1777637601622,"version":"3.51.4"},"reference-count":20,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T00:00:00Z","timestamp":1289865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:p>Hughes MG Jr, Khan KM, Gruessner AC, Sharp H, Hill M, Jie T, Kandaswamy R, Humar A, Payne WD, Gruessner RWG. Long\u2010term outcome in 42 pediatric liver transplant patients with alpha 1\u2010antitrypsin deficiency: a single\u2010center experience.\u2028Clin Transplant 2011: 25: 731\u2013736. \u00a9 2010 John Wiley &amp; Sons A\/S.<\/jats:p><jats:p><jats:bold>Abstract:\u2002<\/jats:bold><jats:bold> Introduction:\u2002<\/jats:bold> We examined the long\u2010term outcome of transplantation for alpha 1\u2010antitrypsin deficiency (A1ATD).<\/jats:p><jats:p><jats:bold>Method:\u2002<\/jats:bold> Data were reviewed on 42 transplants in 35 children with A1ATD over 42\u2003yr and compared with 129 transplants in 116 children with biliary atresia (BA).<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Over 50% of patients were followed up for &gt;10\u2003yr. A1ATD were older than BA at transplantation, median age, 6.0 vs. 1.0\u2003yr (p\u2003&lt;\u20030.0001), and transplanted earlier in the course of liver failure (total bilirubin, 2.7\u2003mg\/dL [1.4\u20136.9] vs. 9.7\u2003mg\/dL [2.9\u201315.4], p\u2003=\u20030.005). Patient survival was greater in A1ATD than BA: one\u2010yr post\u2010transplant, 82.7% vs. 67.9%; five\u2003yr, 76.5% vs. 60.2%; and 10\u2003yr, 76.5% vs. 55.9% (p\u2003=\u20030.03). Death\u2010censored graft survival was similar: one\u2010yr post\u2010transplant, 68.4% vs. 66.2%; five\u2003yr, 68.4% vs. 55.8%; and 10\u2003yr, 68.4% vs. 52.5% (p\u2003=\u20030.2). Deaths were from infection, hemorrhage, and graft failure &lt;6\u2003months post\u2010transplant. Patient survival improved at five\u2003yr from 33.3% pre\u2010cyclosporine (CSA) (1969\u20131984) (n\u2003=\u20036) to 76.5% in the CSA era (1985\u20131994) (n\u2003=\u200317) and 100% with tacrolimus (1995\u20132006) (n\u2003=\u200312) (p\u2003=\u20030.007).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> The age at transplantation and the degree of liver dysfunction were related to the differences in graft and patient survival between A1AT and BA.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2010.01371.x","type":"journal-article","created":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T09:30:33Z","timestamp":1289899833000},"page":"731-736","source":"Crossref","is-referenced-by-count":25,"title":["Long\u2010term outcome in 42 pediatric liver transplant patients with alpha 1\u2010antitrypsin deficiency: a single\u2010center experience"],"prefix":"10.1111","volume":"25","author":[{"suffix":"Jr","given":"Michael G.","family":"Hughes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika C.","family":"Gruessner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tun","family":"Jie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Kandaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Humar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer W. G.","family":"Gruessner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,11,16]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02125800"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(05)70371-8"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80103-8"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197606102942404"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00082-0"},{"key":"e_1_2_5_7_2","first-page":"315","article-title":"An analysis of the OPTN\/UNOS Liver Transplant Registry","author":"Futagawa Y","year":"2004","journal-title":"Clin Transplant"},{"key":"e_1_2_5_8_2","first-page":"669","article-title":"Change in alpha 1\u2010antitrypsin phenotype after orthotopic liver transplant","volume":"66","author":"Van Furth R","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0950-3528(89)90031-6"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000131602.35978.98"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70152-5"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80478-3"},{"key":"e_1_2_5_13_2","first-page":"3798","article-title":"Orthotopic liver transplantation for alpha\u20101\u2010antitrypsin deficiency: an experience in 29 children and ten adults","volume":"19","author":"Esquivel CO","year":"1987","journal-title":"Transplant Proc"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80469-6"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1995.tb01704.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199605270-00014"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2000.tb01068.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50089"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.04.073"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20358"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000062570.83203.A3"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2010.01371.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2010.01371.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:33:59Z","timestamp":1697405639000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2010.01371.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,16]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1111\/j.1399-0012.2010.01371.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2010.01371.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,16]]}}}